Peter Jandus

486 total citations
29 papers, 240 citations indexed

About

Peter Jandus is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, Peter Jandus has authored 29 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Rheumatology and 7 papers in Surgery. Recurrent topics in Peter Jandus's work include Urticaria and Related Conditions (9 papers), Mast cells and histamine (9 papers) and Drug-Induced Adverse Reactions (6 papers). Peter Jandus is often cited by papers focused on Urticaria and Related Conditions (9 papers), Mast cells and histamine (9 papers) and Drug-Induced Adverse Reactions (6 papers). Peter Jandus collaborates with scholars based in Switzerland, Germany and Italy. Peter Jandus's co-authors include Arthur Helbling, Oliver Hausmann, Gabrielle Haeberli, Camilla Jandus, Ulrich Müller, Michael Fricker, Sara Trabanelli, Basile N. Landis, Bérengère Salomé and Domenico Mavilio and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Vascular Surgery and Clinical & Experimental Allergy.

In The Last Decade

Peter Jandus

24 papers receiving 231 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Jandus Switzerland 8 110 102 52 50 46 29 240
Julij Šelb Slovenia 9 163 1.5× 206 2.0× 38 0.7× 77 1.5× 67 1.5× 24 364
Joanna Glück Poland 10 131 1.2× 110 1.1× 68 1.3× 30 0.6× 19 0.4× 51 328
Andrzej Obojski Poland 11 86 0.8× 80 0.8× 17 0.3× 26 0.5× 9 0.2× 31 277
Fabio Lodi Rizzini Italy 8 45 0.4× 146 1.4× 15 0.3× 94 1.9× 27 0.6× 16 242
Panteha Eshtiaghi Canada 5 62 0.6× 164 1.6× 46 0.9× 104 2.1× 4 0.1× 10 356
Jeanne Allinne United States 5 170 1.5× 180 1.8× 99 1.9× 59 1.2× 7 0.2× 12 487
Dylan Birchard United States 5 172 1.6× 181 1.8× 100 1.9× 59 1.2× 7 0.2× 12 491
Sofia Necander Sweden 6 35 0.3× 150 1.5× 71 1.4× 61 1.2× 14 0.3× 18 334
Michiya Yamaguchi Japan 5 29 0.3× 54 0.5× 35 0.7× 31 0.6× 9 0.2× 14 169
Daniel S Pratt United States 4 28 0.3× 231 2.3× 66 1.3× 72 1.4× 6 0.1× 5 321

Countries citing papers authored by Peter Jandus

Since Specialization
Citations

This map shows the geographic impact of Peter Jandus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Jandus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Jandus more than expected).

Fields of papers citing papers by Peter Jandus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Jandus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Jandus. The network helps show where Peter Jandus may publish in the future.

Co-authorship network of co-authors of Peter Jandus

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Jandus. A scholar is included among the top collaborators of Peter Jandus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Jandus. Peter Jandus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stolz, Daiana, et al.. (2024). Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study. Journal of Asthma and Allergy. Volume 17. 1301–1312. 2 indexed citations
2.
Jandus, Peter, et al.. (2024). Successful desensitization to etoposide in a patient after cardiac arrest. Journal of Oncology Pharmacy Practice. 31(2). 336–340.
3.
Zgheib, Omar, et al.. (2022). Drug-induced hypersensitivity syndrome with lupus manifestations due to mesalazine in a patient with ulcerative colitis. BMJ Case Reports. 15(2). e248229–e248229. 1 indexed citations
4.
Ercolano, Giuseppe, et al.. (2021). Healthy and Patient Type 2 Innate Lymphoid Cells are Differently Affected by in vitro Culture Conditions. Journal of Asthma and Allergy. Volume 14. 773–783. 7 indexed citations
6.
Jandus, Peter, et al.. (2020). Using Baseline and Peak Serum Tryptase Levels to Diagnose Anaphylaxis: a Review. Clinical Reviews in Allergy & Immunology. 58(3). 366–376. 35 indexed citations
7.
Maul, Julia‐Tatjana, Urs C. Steiner, Peter Jandus, et al.. (2020). Efficacy of Omalizumab in Mastocytosis: Allusive Indication Obtained from a Prospective, Double-Blind, Multicenter Study (XOLMA Study). Dermatology. 236(6). 529–539. 17 indexed citations
8.
Harr, Thomas, et al.. (2019). Long-term Remission of Wells Syndrome With Omalizumab. Journal of Investigational Allergology and Clinical Immunology. 30(1). 58–59. 2 indexed citations
9.
Jandus, Peter, et al.. (2018). Syndrome d’activation mastocytaire. Revue Médicale Suisse. 14(601). 742–745.
10.
Harr, Thomas & Peter Jandus. (2018). Late Diagnosis of Anaphylactic Reaction to Gadolinium-Based Contrast Media by Skin Tests 10 Years After Onset. Journal of Investigational Allergology and Clinical Immunology. 28(3). 203–205. 5 indexed citations
11.
Harr, Thomas, et al.. (2018). [Allergology and clinical immunology].. PubMed. 14(588-589). 15–18. 3 indexed citations
12.
Jandus, Peter, et al.. (2018). [Mastcell activation syndrome].. PubMed. 14(601). 742–745. 3 indexed citations
13.
Jaques, Darrell A., et al.. (2017). Anaphylactic shock following castor bean contact: a case report. Allergy Asthma and Clinical Immunology. 13(1). 50–50. 2 indexed citations
14.
Spoerl, David, et al.. (2017). Anaphylactic shock to H1 antihistamine drug bilastine: A case report. The Journal of Allergy and Clinical Immunology In Practice. 6(1). 256–257. 1 indexed citations
15.
Trabanelli, Sara, Alejandra Gomez‐Cadena, Bérengère Salomé, et al.. (2017). Human innate lymphoid cells (ILCs): Toward a uniform immune‐phenotyping. Cytometry Part B Clinical Cytometry. 94(3). 392–399. 45 indexed citations
16.
Roffi, Marco, et al.. (2016). Recurrent Vasospastic Myocardial Infarctions and Hand Necrosis. JACC: Cardiovascular Interventions. 10(2). 198–199. 1 indexed citations
17.
Haeberli, Gabrielle, Peter Jandus, Oliver Hausmann, et al.. (2011). An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell‐mediated hypersensitivity reaction: a prospective study in Hymenoptera venom allergic patients. Clinical & Experimental Allergy. 41(12). 1777–1783. 54 indexed citations
18.
Györik, Sándor, Peter Jandus, & Claudio Marone. (2009). Urinanalysis (UA): a neglected but easy and inexpensive diagnostic tool. Clinical Kidney Journal. 2(5). 354–356. 3 indexed citations
19.
Tschopp, Jean‐Marie, et al.. (2009). La [b]hernie[/b] de Bochdalek, cause rare de dyspnée et de douleurs abdominales chez l’adulte. Revue Médicale Suisse. 5(203). 1061–1064.
20.
Jandus, Peter, et al.. (2009). [Bochdalek hernia: a rare cause of dyspnea and abdominal pain in adults].. PubMed. 5(203). 1061–4. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026